unmet needs and therapeutic strategies in essential thrombocythemia
Published 2 years ago • 685 plays • Length 3:29Download video MP4
Download video MP3
Similar videos
-
8:07
essential thrombocythemia: outcomes, unmet needs, and therapeutic strategies
-
0:35
novel therapeutics in essential thrombocythemia
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:12
unmet needs in et and future considerations
-
1:25
exciting updates in essential thrombocythemia: exploring novel agents
-
5:21
challenges in the treatment and management of et and the need to improve therapeutic approaches
-
6:40
doctor explains high platelet count (thrombocytosis) | causes, symptoms and more
-
26:51
ascp | mls | mlt | essential thrombocythemia | myeloproliferative neoplasms
-
2:01:47
conversation with mpn specialists: focus on essential thrombocythemia
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
1:05
unmet needs in gvhd & the promise of regenerative medicine
-
2:15
advances in the risk stratification and treatment of essential thrombocythemia
-
1:57
surpass et: p1101 in essential thrombocythemia
-
3:11
unmet needs in bpdcn and strategies to optimize care for patients
-
1:13
the unmet needs and future of cmml treatment
-
1:20
unmet needs in mpn treatment
-
2:03
unmet needs in immune thrombocytopenia
-
3:21
the current standard of care for patients with essential thrombocythemia
-
1:05
hematological predictors of thrombotic risk or disease progression in essential thrombocythemia